Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and ALS - Amyotrophic Lateral Sclerosis

2-amino-5-phosphonovalerate has been researched along with ALS - Amyotrophic Lateral Sclerosis in 3 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sen, I1
Nalini, A1
Joshi, NB1
Joshi, PG1
Couratier, P1
Hugon, J1
Sindou, P1
Vallat, JM1
Dumas, M1
Mennini, T1
Cagnotto, A1
Carvelli, L1
Comoletti, D1
Manzoni, C1
Muzio, V1
Rizzi, M1
Vezzani, A1

Other Studies

3 other studies available for 2-amino-5-phosphonovalerate and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
    Journal of the neurological sciences, 2005, Aug-15, Volume: 235, Issue:1-2

    Topics: 2-Amino-5-phosphonovalerate; Amyotrophic Lateral Sclerosis; Analysis of Variance; Animals; Calcium;

2005
Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors.
    Lancet (London, England), 1993, Jan-30, Volume: 341, Issue:8840

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Aged; Amino Acids; Amyotrophic La

1993
Biochemical and pharmacological evidence of a functional role of AMPA receptors in motor neuron dysfunction in mnd mice.
    The European journal of neuroscience, 1999, Volume: 11, Issue:5

    Topics: 2-Amino-5-phosphonovalerate; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amyotrophic L

1999